Prognostic value of a simplified score based on routine parameters in patients with hepatocellular carcinoma treated with systemic therapies: a retrospective cohort study
This simplified prognostic score, based on three routine laboratory parameters, stratifies survival outcomes in HCC patients receiving either sorafenib or immunotherapy. While further validation is needed in larger and more diverse populations, this tool may support individualized clinical counseling and risk-adapted trial design.
Authors
- Jorge Sabbaga (ORCID: https://orcid.org/0000-0003-0715-4670)
- Victor Junji Yamamoto (ORCID: https://orcid.org/0000-0002-1422-0042)
- Marina Acevedo Zarzar de Melo (ORCID: https://orcid.org/0000-0002-3031-7928)
- Leonardo Gomes da Fonseca (ORCID: https://orcid.org/0000-0002-0216-3618)
- Lucas Takeshi Ikeoka (ORCID: https://orcid.org/0000-0003-1916-653X)
- Thamires Haick Martins da Silveira
- Pedro H. Hashizume (ORCID: https://orcid.org/0000-0002-9159-6756)
Institutions
- Instituto do Câncer do Estado de São Paulo (BR)
Publication Details
- Journal
- Journal of Gastrointestinal Oncology
- Published
- 2025-10-01
- DOI
- https://doi.org/10.21037/jgo-2024-988
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00